Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-04

Clinical Trial Update: Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing hypo-fractionated radiation therapy with vs without androgen suppression for intermediate-risk prostate cancer; the study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Proton Collaborative Group | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING